Patents Assigned to Tagra Biotechnologies Ltd.
  • Patent number: 11065593
    Abstract: Microcapsules encapsulating a reflective agent are provided herein. The microcapsules are comprised of an inner core, which comprises the reflective agent and optionally an oily substance, and an outer shell formed of wall-forming polymeric materials. The microcapsules may further comprise an opaque substance and/or a fatty acyl salt in the outer shell. Processes of preparing the microcapsules are also provided.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: July 20, 2021
    Assignee: Tagra Biotechnologies Ltd.
    Inventors: Danny Goldstein, Shaher Duchi, Lior Ben-Altabet, Yaniv Menachem, Olga Privalova, Hanan Haj, Audrey Ricard
  • Publication number: 20200281827
    Abstract: Microcapsules comprised of a core comprising one or more sunscreen agents and a shell of a wall-forming polymeric material, which are non-rupturable upon rubbing or pressing on the skin, and processes of preparing same are disclosed. Topical formulations comprising the microcapsules, which can be, for example, sunscreen formulations or skin care formulations, are also provided.
    Type: Application
    Filed: May 27, 2020
    Publication date: September 10, 2020
    Applicant: Tagra Biotechnologies Ltd.
    Inventors: Danny GOLDSTEIN, Olga PRIVALOVA, Lior BEN-ALTABET, Yaniv MENACHEM, Hanan HAJ
  • Patent number: 10449127
    Abstract: Monolayered microcapsules comprising a black pigment and cosmetic formulations comprising them are provided for use particularly in mascara and eye liner formulations. The black pigment may be carbon black, black iron oxide, or both.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: October 22, 2019
    Assignee: Tagra Biotechnologies, Ltd.
    Inventors: Danny Goldstein, Yuri Yasman, Olga Privalova, Lior Benaltabet
  • Patent number: 9682031
    Abstract: The present invention provides microcapsules comprising benzoyl peroxide and topical compositions comprising them, optionally along with other active ingredients, particularly for the treatment of acne.
    Type: Grant
    Filed: October 7, 2010
    Date of Patent: June 20, 2017
    Assignee: Tagra Biotechnologies Ltd.
    Inventors: Danny Goldstein, Tal Sade, Yuri Yasman, Olga Privalova, Lior Benaltabet
  • Publication number: 20110229536
    Abstract: Color-changing cosmetic or therapeutic compositions for topical application are provided, comprising one or more active substances and one or more microencapsulated colorants, which upon application on the skin provide a changing color effect that indicates the delivery of the active substances from said composition onto the skin and/or gives to the skin a visual esthetical effect.
    Type: Application
    Filed: May 12, 2009
    Publication date: September 22, 2011
    Applicant: Tagra Biotechnologies Ltd.
    Inventors: Emma Kvitnitsky, Irena Paluy, Irena Oleinik, Tal Sade, Yuri Yasman
  • Patent number: 7838037
    Abstract: The present invention provides methods for microencapsulation of active ingredients for topical application, whereby double-layer and triple-layer microcapsules are obtained. The microcapsules protect the active ingredients, maintain their original activity throughout processing, formulation and storage, and enable controlled release of the active ingredient only upon application onto the skin.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: November 23, 2010
    Assignee: Tagra Biotechnologies Ltd.
    Inventors: Emma Kvitnitsky, Yury Shapiro, Olga Privalov, Irena Oleinik, Igor Polisher
  • Publication number: 20070167517
    Abstract: Ascorbic acid derivatives of the general formula 1: wherein R<1> is a C2-C22 acyl group, an amino acid group, or a C1-C17 alkyl group; R<2> is ammonium or a metal cation; and each of R<3> or R<4>, independently, is hydrogen, a C2-C22 acyl group, an amino acid residue, or a C1-C17 alkyl group, are more stable than ascorbic acid and can be used as a source of vitamin C in pharmaceutical, nutraceutical and cosmetic compositions.
    Type: Application
    Filed: April 21, 2004
    Publication date: July 19, 2007
    Applicant: Tagra Biotechnologies Ltd.
    Inventors: Emma Kvitnitsky, Valery Belakhov, Vladimir Babtsov, Vury Shapiro
  • Patent number: 7045546
    Abstract: Novel derivatives of ascorbic acid and compositions comprising them are provided. The novel derivatives are of the following general formula (I): where R1 is a C2–C22 saturated or unsaturated fatty acid residues, amino acid residues, or a C1–C17 alkyl ; R2 is a group of the following formula (II) wherein R5 or R6 are the same or different and represent hydrogen, a C1–C4 alkyl, or R5 is C1–C4 alkyl group and R6 is a metal cation or ammonium cation; R3 or R4 are the same or different and represent hydrogen, C2–C22 saturated or unsaturated fatty acid residues, amino acid residues, or a C1–C17 alkyl.
    Type: Grant
    Filed: July 26, 2001
    Date of Patent: May 16, 2006
    Assignee: Tagra Biotechnologies Ltd.
    Inventors: Vladimir Babtsov, Yury Shapiro, Emma Kvitnitsky, Valery Belakhov
  • Publication number: 20060051425
    Abstract: The present invention provides methods for microencapsulation of active ingredients for topical application, whereby single-layer and multi-layer, preferably double-layer, microcapsules, are obtained. The microcapsules protect the active ingredients, maintain their original activity throught processing, formulation and storage, and enable controlled release of the active ingredient only upon application onto the skin.
    Type: Application
    Filed: August 22, 2005
    Publication date: March 9, 2006
    Applicant: Tagra Biotechnologies Ltd.
    Inventors: Emma Kvitnitsky, Yury Shapiro, Olga Privalov, Irena Oleinik, Igor Polisher
  • Patent number: 6932984
    Abstract: A method for microencapsulation of substances is provided. The substance(s) is/are dissolved or dispersed in an organic solvent of the kind that is partially miscible in water media. This organic solution is then mixed with an aqueous solution, which is saturated with an organic solvent and an emulsifier to form an emulsion. The emulsion is then poured into water under continuous agitation for the extraction of residual solvent. The formation of the solid capsules takes place during this extraction process. The capsules are undergone to further purification, whereby the microcapsules can be separated from the water and dried. By conditions of incubation of microcapsules in water-containing formulations the wall-softening process takes place. The unique system for controlled releasing the ingredients from microcapsules is based on the above-mentioned process.
    Type: Grant
    Filed: November 16, 2000
    Date of Patent: August 23, 2005
    Assignee: Tagra Biotechnologies Ltd.
    Inventors: Vladimir Babtsov, Yury Shapiro, Emma Kvitnitsky